Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Praecox”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04352569
What this trial is testing

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

Who this might be right for
SchizophreniaHallucinationsRefractory Schizophrenia
Centre hospitalier de Ville-Evrard, France 25
Not applicableActive Not RecruitingNCT06474195
What this trial is testing

Cue-based Intervention in Prospective Memory and Medication Adherence.

Who this might be right for
Schizophrenia
University of Pittsburgh 104
Not applicableStudy completedNCT01793324
What this trial is testing

EMR Data to Assess Monitoring of Patients Treated With Quetiapine

Who this might be right for
SchizophreniaBipolar DisorderMajor Depressive Disorder
AstraZeneca 6,153
Large-scale testing (Phase 3)Study completedNCT01129882
What this trial is testing

An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 709
Not applicableNot Yet RecruitingNCT07652866
What this trial is testing

Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia

Who this might be right for
Schizophrenia Disorder
Second Xiangya Hospital of Central South University 60
Large-scale testing (Phase 3)Ended earlyNCT00637494
What this trial is testing

Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Who this might be right for
Psychotic DepressionSevere Major Depression With Psychotic FeaturesPsychosis
Corcept Therapeutics 292
Testing effectiveness (Phase 2)Study completedNCT00314639
What this trial is testing

Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

Who this might be right for
Schizophrenia and Schizophrenia Spectrum Psychosis
Laval University 30
Early research (Phase 1)Study completedNCT03730857
What this trial is testing

Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Calo Psychiatric Center 111
Post-approval studies (Phase 4)Study completedNCT00859872
What this trial is testing

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Who this might be right for
Schizophrenia
Central South University 198
Post-approval studies (Phase 4)Study completedNCT00893256
What this trial is testing

Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia

Who this might be right for
SchizophreniaNegative Symptoms
National Institute of Mental Health and Neuro Sciences, India 48
Large-scale testing (Phase 3)Study completedNCT04092686
What this trial is testing

A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 464
Early research (Phase 1)Study completedNCT04010305
What this trial is testing

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

Who this might be right for
AgitationSchizophrenia
BioXcel Therapeutics Inc 135
Very early researchStudy completedNCT00708994
What this trial is testing

Cannabinoids, Neural Synchrony, and Information Processing

Who this might be right for
CannabisPsychotic Disorders
Yale University 42
Not applicableLooking for participantsNCT07056894
What this trial is testing

Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis

Who this might be right for
PsychosisAlcohol Use DisorderCannabis Use Disorder
Nova Scotia Health Authority 50
Not applicableStudy completedNCT06791122
What this trial is testing

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Boehringer Ingelheim 262
Not applicableStudy completedNCT05127837
What this trial is testing

CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies

Who this might be right for
PsychosisSchizophreniaSchizo Affective Disorder+2 more
University of Washington 601
Not applicableNot Yet RecruitingNCT07108673
What this trial is testing

Value of Voxel-Based Morphometry in Schizophrenia

Who this might be right for
Schizophrenia
Assiut University 96
Testing effectiveness (Phase 2)WithdrawnNCT01905605
What this trial is testing

Phosphatidylcholine Supplementation in Infants

Who this might be right for
SchizophreniaDiminished P50 Sensory Gating
University of Colorado, Denver
Not applicableStudy completedNCT00538629
What this trial is testing

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Who this might be right for
Bipolar DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 471
Not applicableUnknownNCT01357005
What this trial is testing

Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan

Who this might be right for
Schizophrenia
Far Eastern Memorial Hospital 300
Next Page